🔗 Permalink

Inventor profile of:

Christoph HOCK

City:

Erlenbach

Country:

Switzerland

Published Applications:

Last publication date:

2024-08-01

Top Assignees for applications by Christoph HOCK

The entities that hold a legal rights for patent applications filed by inventor HOCK Christoph:

UNIVERSITY OF ZURICH 29 Zurich, Switzerland
Biogen International Neuroscience GmbH 9 Zug, Switzerland
Biogen International Neuroscience GmbH 6 Baar, Switzerland
BIOGEN IDEC INTERNATIONAL NEUROSCIENCE GMBH 5 Schlieren, Switzerland
NEURIMMUNE HOLDING AG 3 Schlieren, Switzerland
Neurimmune Holding AG 2 , Switzerland
University of Zurich 2 , Switzerland
UNIVERSITY OF ZÜRICH 1 Zürich, Switzerland
University of Zurich 1 8006 Zurich, Switzerland
Panima Pharmaceuticals AG 1 8952 Schlieren, Switzerland
UNIVERSITAT ZURICH 1 Zurich, Switzerland
BIOGEN IDEC INTERNALTIONAL NEUROSCIENCE GMBH 1 Schlieren, Switzerland

Recent patent applications by HOCK Christoph

Christoph HOCK from Erlenbach, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-08-01

US20240254256A1

Chemistry; metallurgy

Human Anti-SOD1 Antibodies

#2 | 2023-08-03

US20230242624A1

Chemistry; metallurgy

HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2)

#3 | 2022-12-22

US20220403011A1

Chemistry; metallurgy

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

#4 | 2022-08-25

US20220267471A1

Chemistry; metallurgy

Human Anti-SOD1 Antibodies

#5 | 2021-08-05

US20210238265A1

Chemistry; metallurgy

Human Anti-Tau Antibodies

#6 | 2020-01-16

US20200017577A1

Chemistry; metallurgy

TDP-43 specific binding molecules

#7 | 2019-09-19

US20190284302A1

Chemistry; metallurgy

Human anti-SOD1 antibodies

#8 | 2019-08-29

US20190263896A1

Chemistry; metallurgy

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

#9 | 2019-08-01

US20190233506A1

Chemistry; metallurgy

Human Anti-Tau Antibodies

#10 | 2019-05-23

US20190153082A1

Chemistry; metallurgy

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

#11 | 2018-12-27

US20180371065A1

Chemistry; metallurgy

Human anti-alpha-synuclein antibodies

#12 | 2018-12-13

US20180355027A1

Chemistry; metallurgy

Anti-alpha synuclein binding molecules

#13 | 2018-05-17

US20180134773A1

Chemistry; metallurgy

Methods of treating Alzheimer's disease

#14 | 2018-01-04

US20180002409A1

Chemistry; metallurgy

Human Anti-Tau Antibodies

#15 | 2017-10-05

US20170283491A1

Chemistry; metallurgy

Method of providing disease-specific binding molecules and targets

#16 | 2017-08-17

US20170233463A1

Chemistry; metallurgy

Anti-alpha synuclein binding molecules

#17 | 2017-06-01

US20170152308A1

Chemistry; metallurgy

TDP-43 specific binding molecules

#18 | 2016-10-06

US20160289310A1

Chemistry; metallurgy

Method of providing disease-specific binding molecules and targets

#19 | 2016-08-25

US20160244515A1

Chemistry; metallurgy

Human anti-alpha-synuclein antibodies

#20 | 2016-06-16

US20160168267A1

Chemistry; metallurgy

Human anti-SOD1 antibodies

#21 | 2015-09-10

US20150252102A1

Chemistry; metallurgy

Human anti-tau antibodies

#22 | 2015-08-20

US20150232542A1

Chemistry; metallurgy

HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIES

#23 | 2015-05-28

US20150147343A1

Chemistry; metallurgy

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

#24 | 2014-12-18

US20140369940A1

Chemistry; metallurgy

Anti-α synuclein binding molecules

#25 | 2014-10-09

US20140301945A1

Human necessities

Human anti-SOD1 antibodies

#26 | 2014-09-11

US20140255304A1

Chemistry; metallurgy

TDP-43 specific binding molecules

#27 | 2014-02-13

US20140044644A1

Human necessities

ANKYRIN G AND MODULATORS THEREOF FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

#28 | 2013-11-07

US20130295021A1

Chemistry; metallurgy

HUMAN ANTI-TAU ANTIBODIES

#29 | 2013-10-10

US20130266586A1

Human necessities

Method of Providing Disease-Specific Binding Molecules and Targets

#30 | 2013-10-10

US20130266585A1

Chemistry; metallurgy

Method of Providing Disease-Specific Binding Molecules and Targets

#31 | 2013-10-10

US20130266514A1

Chemistry; metallurgy

Method of Providing Disease-Specific Binding Molecules and Targets

#32 | 2013-08-22

US20130216555A1

Chemistry; metallurgy

Method of providing disease-specific binding molecules and targets

#33 | 2012-04-12

US20120087861A1

Chemistry; metallurgy

Human anti-tau antibodies

#34 | 2011-12-08

US20110300077A1

Chemistry; metallurgy

Human anti-alpha-synuclein antibodies

#35 | 2010-08-12

US20100202968A1

Chemistry; metallurgy

Method of providing disease-specific binding molecules and targets

#36 | 2006-10-26

US20060240485A1

Physics

Method of monitoring immunotherapy

#37 | 2005-06-16

US20050130165A1

Physics

Polymorphism of soati useful for identifying risk of developing alzheimer's disease

InventorID:

401033 ⎘